Anthem Biosciences Limited (NSE:ANTHEM)
759.25
+21.45 (2.91%)
Apr 22, 2026, 3:30 PM IST
Anthem Biosciences Market Cap
Anthem Biosciences has a market cap or net worth of 414.36 billion as of April 22, 2026.
Market Cap
414.36B
Enterprise Value
405.14B
Revenue
20.02B
Ranking
n/a
PE Ratio
86.03
Stock Price
759.25
Market Cap Chart
Since July 21, 2025, Anthem Biosciences's market cap has increased from 410.17B to 414.36B, an increase of 1.02%. That is a compound annual growth rate of 1.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 21, 2026 | 414.36B | 13.25% |
| Dec 31, 2025 | 365.89B | -10.80% |
| Jul 21, 2025 | 410.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 579.54B |
| OneSource Specialty Pharma | 176.95B |
| Concord Biotech | 113.16B |
| Blue Jet Healthcare | 73.32B |
| Supriya Lifescience | 51.39B |
| Zota Health Care | 44.54B |
| Dishman Carbogen Amcis | 26.44B |
| Panacea Biotec | 21.97B |